Philadelphia University + Thomas Jefferson University
Institute of Emerging Health Professions
Lambert Center for the Study of Medicinal Cannabis & Hemp

Resources

Recent 'core journal' review articles:

Choo EK, Emery SL. Clearing the haze: the complexities and challenges of research on state marijuana laws. Ann N Y Acad Sci. 2017;1394:55-73. Article conclusion: This review provides a background on marijuana laws in the United States and an overview of existing policy research, discusses methodological considerations when planning analysis of state marijuana laws, and highlights specific topics needing further development and investigation.

Carliner H, Brown QL, Sarvet AL et al. Cannabis use, attitudes, and legal status in the U.S.: A review. Prev Med. 2017;104:13-23. Article conclusion: Multiple nationally representative studies indicate that medical marijuana laws (MMLs) have had little effect on cannabis use among adolescents, [but] available evidence suggests that MMLs increase use and cannabis use disorders in adults. … More permissive marijuana laws may accomplish social justice aims (e.g., reduce racial disparities in law enforcement) and generate tax revenues. However, such laws may increase cannabis-related adverse health and psychosocial consequences by increasing the population of users. Dissemination of balanced information about the potential health harms of cannabis use is needed.

Karl T, Garner B, Cheng D. The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease. Behav Pharmacol. 2017 Apr;28(2 and 3 - Special Issue):142-160. doi: 10.1097/FBP.0000000000000247. Article conclusion: This review presents a brief introduction to AD biology and current treatment options, outlines CBD biology and pharmacology, followed by in-vitro and in-vivo evidence for the therapeutic potential of CBD, discusses the role of the endocannabinioid system in AD, comments on the potential future of CBD for AD therapy (including safety aspects).

Links to websites and online publications:

National Institute on Drug Abuse (NIDA). NIDA Research on Marijuana and Cannabinoids. (last update March 2016)                                                                                                                          

The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. A Report of the National Academies of Sciences, Engineering, and Medicine. 2017. 

                                                                                                      

Resources for Physicians

Links to state medical marijuana program websites (as of November 2017)

Alaska                                                                    

Montana

Arizona     

Nevada
Arkansas    
New Hampshire

California

New Jersey  
Colorado          New Mexico
Connecticut                 
New York 
Delaware                                                                                                      
North Dakota   

Florida        

Ohio

Hawaii                                         

Oregon
Illinois         
Pennsylvania
Maine       
Rhode Island
Maryland                  
Vermont
Massachusetts                                             
Washington

Michigan                      

Washington, DC
Minnesota West Virginia